SCHEMBL23147927

SCHEMBL23147927

Cc1ccn(C2CCC[Si](C)(C)CC2)c1C(F)(F)F

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20370770 0.71 MEN1 (0.31) —
SCHEMBL23148114 0.70 — —
SCHEMBL23148101 0.68 USP2 (0.30) —
SCHEMBL18804533 0.63 ALDH1A1 (0.33) —
SCHEMBL23148142 0.62 — —
SCHEMBL23148165 0.58 — —
SCHEMBL23148110 0.57 — —
SCHEMBL23147881 0.56 — —
SCHEMBL10321426 0.53 SCD (0.37) KCNH2
SCHEMBL10322016 0.53 SCD (0.37) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021062316-A1 AZAINDOLE CARBOXAMIDE COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) 2021-04-01 — — WO disclosed
Send feedback